A Trial of BKM120 (a PI3K Inhibitor) in Patients with Triple Negative Metastatic Breast Cancer - Stand Up To Cancer

Blog

Posted October 14, 2019

A Trial of BKM120 (a PI3K Inhibitor) in Patients with Triple Negative Metastatic Breast Cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.